英国FROST试验:原发性冻结肩三种治疗方案的比较
英国35家医院的多中心实用型三臂优越性随机试验纳入503例原发性冻结肩成人患者,比较麻醉下手法松解、关节镜下关节囊松解与早期结构化物理治疗加类固醇注射。12个月时三组牛津肩关节评分(OSS)平均差异均未达预设目标差异,无干预在临床上更优;关节囊松解严重不良事件较多,麻醉下手法松解最具成本效果。
要点
- 三种干预在12个月OSS上均未达临床优效阈值。
- 关节镜下关节囊松解严重不良事件较多(8例 vs 手法松解2例)。
核心结论
- 12个月时三种干预的OSS平均差异均小于目标差异,无临床优效干预;关节囊松解风险较高,麻醉下手法松解最具成本效果。
研究设计与样本
- 多中心、实用型、三臂、优越性随机对照试验,从英国35家医院招募继发医疗转诊的原发性冻结肩成人患者。
- 纳入标准为≥18岁、单侧冻结肩且患侧被动外旋受限≥50%;按2:2:1随机分配至麻醉下手法松解、关节镜下关节囊松解或早期结构化物理治疗。
- 共筛查914例,503例(55%)被随机分配;12个月时OSS数据可及率各组均为94%。
主要发现
- 严重不良事件:关节囊松解组8例,手法松解组2例。
关键数值与推荐
- 主要结局为随机后12个月牛津肩关节评分(OSS,0–48分)。
- 预设目标差异:物理治疗与任一种手术之间为5个OSS分,手法松解与关节囊松解之间为4个OSS分。
- 物理治疗和术后物理治疗均为最多12周内12次治疗。
临床怎么用
- 三种干预在12个月肩痛与功能上均未显示临床优效,选择需权衡风险与成本。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Manipulation under anaesthesia and arthroscopic capsular release are costly and invasive treatments for frozen shoulder, but their effectiveness remains uncertain. We compared these two surgical interventions with early structured physiotherapy plus steroid injection. METHODS: In this multicentre, pragmatic, three-arm, superiority randomised trial, patients referred to secondary care for treatment of primary frozen shoulder were recruited from 35 hospital sites in the UK. Participants were adults (≥18 years) with unilateral frozen shoulder, characterised by restriction of passive external rotation (≥50%) in the affected shoulder. Participants were randomly assigned (2:2:1) to receive manipulation under anaesthesia, arthroscopic capsular release, or early structured physiotherapy. In manipulation under anaesthesia, the surgeon manipulated the affected shoulder to stretch and tear the tight capsule while the participant was under general anaesthesia, supplemented by a steroid injection. Arthroscopic capsular release, also done under general anaesthesia, involved surgically dividing the contracted anterior capsule in the rotator interval, followed by manipulation, with optional steroid injection. Both forms of surgery were followed by postprocedural physiotherapy. Early structured physiotherapy involved mobilisation techniques and a graduated home exercise programme supplemented by a steroid injection. Both early structured physiotherapy and postprocedural physiotherapy involved 12 sessions during up to 12 weeks. The primary outcome was the Oxford Shoulder Score (OSS; 0-48) at 12 months after randomisation, analysed by initial randomisation group. We sought a target difference of 5 OSS points between physiotherapy and either form of surgery, or 4 points between manipulation and capsular release. The trial registration is ISRCTN48804508. FINDINGS: Between April 1, 2015, and Dec 31, 2017, we screened 914 patients, of whom 503 (55%) were randomly assigned. At 12 months, OSS data were available for 189 (94%) of 201 participants assigned to manipulation (mean estimate 38·3 points, 95% CI 36·9 to 39·7), 191 (94%) of 203 participants assigned to capsular release (40·3 points, 38·9 to 41·7), and 93 (94%) of 99 participants assigned to physiotherapy (37·2 points, 35·3 to 39·2). The mean group differences were 2·01 points (0·10 to 3·91) between the capsular release and manipulation groups, 3·06 points (0·71 to 5·41) between capsular release and physiotherapy, and 1·05 points (-1·28 to 3·39) between manipulation and physiotherapy. Eight serious adverse events were reported with capsular release and two with manipulation. At a willingness-to-pay threshold of £20 000 per quality-adjusted life-year, manipulation under anaesthesia had the highest probability of being cost-effective (0·8632, compared with 0·1366 for physiotherapy and 0·0002 for capsular release). INTERPRETATION: All mean differences on the assessment of shoulder pain and function (OSS) at the primary endpoint of 12 months were less than the target differences. Therefore, none of the three interventions were clinically superior. Arthoscopic capsular release carried higher risks, and manipulation under anaesthesia was the most cost-effective. FUNDING: The National Institute for Health Research Health Technology Assessment programme.
引用
- Rangan A, Brealey SD, Keding A, et al. Management of adults with primary frozen shoulder in secondary care (UK FROST): a multicentre, pragmatic, three-arm, superiority randomised clinical trial. Lancet. 2020. PMID: 33010843. doi:10.1016/S0140-6736(20)31965-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。